Evaluation of the Rationality of Antibiotic Use in Pneumonia Patients Using the Gyssens Method

  • Agustiana Universitas Halu Oleo, Indonesia
  • Adryan Fristiohady Universitas Halu Oleo, Indonesia
  • Muhammad Arba Universitas Halu Oleo, Indonesia
  • Asriullah Jabbar Universitas Halu Oleo, Indonesia
  • Nur Illiyyin Akib Universitas Halu Oleo, Indonesia
  • Suryani Universitas Halu Oleo, Indonesia
Keywords: Pneumonia, Antibiotics, Rational Use, Gyssens Method

Abstract

Pneumonia is one of the leading causes of morbidity and mortality worldwide. The irrational use of antibiotics in pneumonia management can reduce therapeutic effectiveness and increase the risk of antimicrobial resistance. This study aimed to evaluate the rationality of antibiotic use in pneumonia patients at Hospital X using the Gyssens method. This research employed a descriptive observational design with a retrospective approach, utilizing medical record data of adult inpatients diagnosed with pneumonia during the period of January–December 2024. A total of 86 patient records meeting the inclusion criteria were analyzed. Evaluation was conducted using the Gyssens method by comparing the appropriateness of therapy with the Guidelines for the Management of Adult Pneumonia issued by the Indonesian Ministry of Health (Regulation No. 28 of 2021) and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS, 2023) guidelines. The results showed that the most frequently used antibiotics were Ceftriaxone (34.88%), Azithromycin (32.56%), and Levofloxacin (32.56%). The most common duration of therapy was five days (53.9%). Based on the Gyssens categories, rational antibiotic use (category 0) was found in 57 cases (66.28%), while the remaining cases were categorized as I (6.98%), IIa (11.63%), IIIa (9.30%), and IIIb (5.81%). These findings indicate that most antibiotic use at Hospital X was rational; however, continuous monitoring and periodic evaluation through the Antimicrobial Resistance Control Program (PPRA) are still necessary to optimize therapeutic effectiveness and prevent antibiotic resistance.

References

Abeja, C. J., Niyonzima, V., Byagamy, J. P., & Obua, C. (2022). Antibiotic prescription rationality and associated in-patient treatment outcomes in children under-five with severe pneumonia at Bwizibwera health center IV, Mbarara District, South-Western Uganda. Pneumonia, 14(1), 3. https://doi.org/10.1186/s41479-022-00095-0

Azmi, S., Aljunid, S. M., Maimaiti, N., Ali, A. A., Nur, A. M., De Rosas-Valera, M., ... & Roberts, C. (2016). Assessing the burden of pneumonia using administrative data from Malaysia, Indonesia, and the Philippines. International Journal of Infectious Diseases, 49, 87-93. https://doi.org/10.1016/j.ijid.2016.05.021

Begum, T., Khan, M. I., Kawser, S., Huq, M. E., Majid, N., & Akhter, A. (2014). An audit of rational use of antibiotics in a tertiary hospital. Delta Medical College Journal, 2(2), 64-67. https://doi.org/10.3329/dmcj.v2i2.20526

Berger, M. L., Dreyer, N., Anderson, F., Towse, A., Sedrakyan, A., & Normand, S. L. (2012). Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. Value in Health, 15(2), 217-230. https://doi.org/10.1016/j.jval.2011.12.010

Berger, M. L., Mamdani, M., Atkins, D., & Johnson, M. L. (2009). Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I. Value in health, 12(8), 1044-1052. https://doi.org/10.1111/j.1524-4733.2009.00600.x

Dewi, R., Sutrisno, D., & Safitri, M. R. (2022). Rasionalitas Penggunaan Antibiotik Pada Pasien Infeksi Saluran Pernapasan Di Puskesmas Rawat Inap Kampung Laut Tahun 2019. Ibnu Sina: Jurnal Kedokteran Dan Kesehatan-Fakultas Kedokteran Universitas Islam Sumatera Utara, 21(1), 91-99. https://doi.org/10.30743/ibnusina.v21i1.202

Ermawati, E., Khambri, D., & Almasdy, D. (2021). The Difference of Using Antibiotics Before and After Antimicrobial Resistance Control Program (PPRA) at RSUP Dr. M. Djamil Padang. Andalas Obstetrics and Gynecology Journal, 5(1), 29-42. https://doi.org/10.25077/aoj.5.1.29-42.2021

Esposito, S., Argentiero, A., Rebecchi, F., Fainardi, V., Pisi, G., & Principi, N. (2022). The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia. Expert Opinion on Pharmacotherapy, 23(4), 497-505. https://doi.org/10.1080/14656566.2022.2028773

Feldman, C., & Shaddock, E. (2019). Epidemiology of lower respiratory tract infections in adults. Expert Review of Respiratory Medicine, 13(1), 63-77. https://doi.org/10.1080/17476348.2019.1555040

Gundler, C., Gottfried, K., Wiederhold, A. J., Ataian, M., Wurlitzer, M., Gewehr, J. E., & Ückert, F. (2024). Unlocking the potential of secondary data for public health research: Retrospective study with a novel clinical platform. Interactive Journal of Medical Research, 13(1), e51563. https://doi.org/10.2196/51563

Gyssens, I. C. (2011). Antibiotic policy. International journal of antimicrobial agents, 38, 11-20. https://doi.org/10.1016/j.ijantimicag.2011.09.002

Hadi, U., Keuter, M., Van Asten, H., Van Den Broek, P., & study group ‘Antimicrobial resistance in Indonesia: Prevalence and Prevention’(AMRIN). (2008). Optimizing antibiotic usage in adults admitted with fever by a multifaceted intervention in an Indonesian governmental hospital. Tropical Medicine & International Health, 13(7), 888-899. https://doi.org/10.1111/j.1365-3156.2008.02080.x

Hadiq, S., Bunyanis, F., Wulandari, N. A., & Basri, W. (2024). Evaluasi Penggunaan Antibiotik pada Pasien Pneumonia Dewasa Rawat Inap di RSUD Nene Mallomo Kabupaten Sidrap. Media Informasi, 20(2), 72-79. https://doi.org/10.37160/mijournal.v20i2.632

Handayany, G. N., & Yuliana, D. (2023). Evaluasi Penggunaan Antibiotik Pasien Pneumonia Dengan Metode Gyssens. Jurnal Insan Farmasi Indonesia, 29-39. https://doi.org/0.36387/jifi.v6i3.1866

Harun, M. G. D., Anwar, M. M. U., Sumon, S. A., Hassan, M. Z., Mohona, T. M., Rahman, A., ... & Styczynski, A. R. (2022). Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: A study protocol. BMC health services research, 22(1), 1239. https://doi.org/10.1186/s12913-022-08603-0

Hou, J., Long, X., Wang, X., Li, L., Mao, D., Luo, Y., & Ren, H. (2023). Global trend of antimicrobial resistance in common bacterial pathogens in response to antibiotic consumption. Journal of Hazardous Materials, 442, 130042. https://doi.org/10.1016/j.jhazmat.2022.130042

Jansen, A. C., van Aalst-Cohen, E. S., Hutten, B. A., Büller, H. R., Kastelein, J. J., & Prins, M. H. (2005). Guidelines were developed for data collection from medical records for use in retrospective analyses. Journal of clinical epidemiology, 58(3), 269-274. https://doi.org/10.1016/j.jclinepi.2004.07.006

Limato, R., Lazarus, G., Dernison, P., Mudia, M., Alamanda, M., Nelwan, E. J., ... & Hamers, R. L. (2022). Optimizing antibiotic use in Indonesia: A systematic review and evidence synthesis to inform opportunities for intervention. The Lancet Regional Health-Southeast Asia, 2.

Lokida, D., Farida, H., Triasih, R., Mardian, Y., Kosasih, H., Naysilla, A. M., ... & Lane, C. (2022). Epidemiology of community-acquired pneumonia among hospitalised children in Indonesia: a multicentre, prospective study. BMJ open, 12(6), e057957. https://doi.org/10.1136/bmjopen-2021-057957

Morshed, S., Tornetta III, P., & Bhandari, M. (2009). Analysis of observational studies: a guide to understanding statistical methods. JBJS, 91(Supplement_3), 50-60. https://doi.org/10.2106/JBJS.H.01577

Mylotte, J. M., Ksiazek, S., & Bentley, D. W. (1994). Rational approach to the antibiotic treatment of pneumonia in the elderly. Drugs & Aging, 4(1), 21-33. https://doi.org/10.2165/00002512-199404010-00003

Notoatmodjo, S. (2014). Metode Penelitian Ilmu Kesehatan. Jakarta: Rineka Cipta.

Pulcini, C., & Gyssens, I. C. (2013). How to educate prescribers in antimicrobial stewardship practices. Virulence, 4(2), 192-202. https://doi.org/10.4161/viru.23706

Purba, A. K., Ascobat, P., Muchtar, A., Wulandari, L., Rosyid, A. N., Purwono, P. B., ... & Postma, M. J. (2019). Multidrug-resistant infections among hospitalized adults with community-acquired pneumonia in an Indonesian tertiary referral hospital. Infection and Drug Resistance, 3663-3675. https://doi.org/10.2147/IDR.S217842

Sadli, N. K., Halimah, E., Winarni, R., & Widyatmoko, L. (2022). Implementasi rasionalitas penggunaan antibiotik pada beberapa rumah sakit di indonesia: kajian literatur mengenai kualitas dan tantangannya.

Saragih, P., Sihombing, V. E., & Pardede, I. B. Y. (2022). Factors that cause the increase of pneumonia in Indonesia. AMCA Journal of Community Development, 2(1), 31-33. https://doi.org/10.51773/ajcd.v2i1.116

Scott, P. J., Rigby, M., Ammenwerth, E., McNair, J. B., Georgiou, A., Hyppönen, H., ... & Hackl, W. (2017). Evaluation considerations for secondary uses of clinical data: principles for an evidence-based approach to policy and implementation of secondary analysis. Yearbook of medical informatics, 26(01), 59-67. https://doi.org/10.15265/IY-2017-010

Sibadu, M. S. A., Meswara, A. N., & Fiskia, E. (2025). Rasionalitas dan Efektivitas Antibiotik pada Pasien Pediatrik Community-Acquired Pneumonia di Rumah Sakit Kota Ternate. Jurnal Farmasi Higea, 17(2), 104-113. https://dx.doi.org/10.52689/higea.v17i2.730

Sugiyono, P. D. (2022). Metode Penelitian Kuantitatif, Kualitatif dan R&D. Bandung: Alfabeta

Susanto, M., OktamiQanti, P., & Anggraini, D. (2019, February). Decline in antibiotic use after implementation of restriction program at eka hospital, Pekanbaru, Riau. In The International Conference on Public Health Proceeding (Vol. 4, No. 01, pp. 491-491). https://doi.org/10.26911/theicph.2019.04.44

Sutriana, V. N., Sitaresmi, M. N., & Wahab, A. (2021). Risk factors for childhood pneumonia: a case-control study in a high prevalence area in Indonesia. Clinical and experimental pediatrics, 64(11), 588. https://doi.org/10.3345/cep.2020.00339

Syam, R. A., & Karuniawati, H. Antibiotic Evaluation of Hospitalized Pneumonia Patients Using Gyssen or DDD 100 Bed Days or DDD 1000 Patient Days. Pharmacon: Jurnal Farmasi Indonesia, 21, 49-64. https://doi.org/10.23917/pharmacon.v21i0.23589

Troeger, C., Forouzanfar, M., Rao, P. C., Khalil, I., Brown, A., Swartz, S., ... & Mokdad, A. H. (2017). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Infectious Diseases, 17(11), 1133-1161.

Widiyastuti, A., Kumala, S., Utami, H., & Pratama, A. (2023). Hubungan rasionalitas penggunaan antibiotik terhadap luaran klinis pasien pneumonia komunitas rawat inap. Jurnal Kesehatan, 14(1), 109-116. https://doi.org/10.26630/jk.v14i1.3483

Wori, P. A., Wiyono, W. I., & Jayanti, M. (2025). Evaluasi Rasionalitas Penggunaan Regimen Antibiotik Pada Pasien Pneumonia di Instalasi Rawat Inap RSUP Prof. Dr. RD Kandou Manado. Jurnal Lentera Farma, 4(1), 01-08. https://doi.org/10.57207/a0c2cq37

Published
2026-01-05
How to Cite
Agustiana, A., Fristiohady, A., Arba, M., Jabbar, A., Akib, N. I., & Suryani, S. (2026). Evaluation of the Rationality of Antibiotic Use in Pneumonia Patients Using the Gyssens Method. Journal La Medihealtico, 6(6), 1596-1606. https://doi.org/10.37899/journallamedihealtico.v6i6.2757